Main Menu

Medicine (de Bono) Drug Development Unit

Professor de Bono's Drug Development Unit is responsible for early clinical trials of novel cancer drugs.

Team leader

Professor Johann de Bono

Professor Johann de Bono

Regius Professor of Cancer Research

Professor Johann de Bono is Head of the Division of Clinical Studies and an international expert in the development of molecularly targeted cancer therapies against adult cancers. He runs one of the world’s largest phase I clinical trials units for cancer and has also led phase III trials of the prostate cancer drugs abiraterone and cabazitaxel.

ORCID 0000-0002-2034-595X

Team members

Dr Alex Lee

Clinical Research Fellow

Anna Zachariou

Clinical Trial Coordinator